BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2013
View Archived Issues
Kinexus updates on PhosphoNET KnowledgeBase
Read More
New immunohistochemistry kit for diagnosis and prognosis of invasive tumors
Read More
New means of converting stem cells to naive state discovered at Minerva Biotechnologies
Read More
Stanford University presents new PKC-delta inhibitors
Read More
Scientists at the University of Utah present novel LSD1 inhibitors for cancer
Read More
Diaxonhit presents new DYRK1A/1B inhibitors
Read More
Vasomera demonstrates improvement in left ventricular function in vivo
Read More
Preclinical results for intranasal gemcitabine
Read More
Danegaptide hydrochloride shown to reduce infarct size in vivo
Read More
Tenecteplase significantly affects primary outcome measure in PEITHO trial
Read More
Tragara Pharmaceuticals presents pharmacokinetic data for TG-02 citrate
Read More
Boehringer Ingelheim presents new agents for viral infections
Read More
Merck KGaA divulges new FAK inhibitors
Read More
Takeda Pharmaceutical synthesizes new DAAO inhibitors
Read More
Gedeon Richter and Orion Corporation to collaborate on cognitive disorders
Read More
Biogen Idec submits BLA for factor VIII therapy
Read More
Chimerix's CMX-001 obtains FDA fast track status for cytomegalovirus infections
Read More
Vifor Pharma reports new regulatory submission for PA-21 in Switzerland
Read More
Shire acquires biotechnology company
Read More
Lithera begins phase IIb trial of LIPO-202 for the reduction of subcutaneous fat
Read More
Detailed results from CHAMPION PHOENIX cangrelor trial presented
Read More
Presidio and Boehringer Ingelheim to collaborate on study of combination treatment for HCV infection
Read More
Armetheon to develop tecarfarin as alternative to warfarin
Read More
Qurient gains exclusive worldwide rights to new kinase inhibitor for metastatic cancer
Read More
FDA approves IND for phase I/II trial of ACT's hESC-derived cells to treat severe myopia
Read More